Intraarterial Catheter-directed Urokinase Infusion for Femoral Artery Thrombosis after Cardiac Catheterization in Infants and Children.
- Author:
Hyoung Doo LEE
1
Author Information
1. Department of Pediatrics, College of Medicine, Dong-A University, Pusan, Korea. hdlee@daunet.donga.ac.kr
- Publication Type:Original Article
- Keywords:
Cardiac catheterization;
Femoral artery thrombosis;
Urokinase
- MeSH:
Angioplasty, Balloon;
Cardiac Catheterization*;
Cardiac Catheters*;
Catheterization;
Catheters;
Child*;
Extremities;
Femoral Artery*;
Hemorrhage;
Heparin;
Humans;
Incidence;
Infant*;
Infusions, Intra-Arterial;
Ischemia;
Medical Records;
Retrospective Studies;
Thrombosis*;
Urokinase-Type Plasminogen Activator*
- From:Journal of the Korean Pediatric Society
2002;45(11):1397-1402
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: One of the major complication of arterial catheterization is the thrombosis of the iliac or femoral arteries. Tissue loss following femoral artery catheterization is rare. However long- term sequelae such as impaired limb growth and future impairment of vascular access, are also important in pediatric cardiac patients. But standard methods to treat thrombotic complication of arterial catheterization in infants and children is not established. The present study was performed to assess the efficacy of intraarterial catheter-directed urokinase infusion in infants and children with limb ischemia due to arterial thrombosis after cardiac catheterization. METHODS: From January 1994 to August 2002, 12 patients with thrombotic femoral artery occlusion after arterial catheterization were treated with catheter-directed urokinase infusion in Dong-A University Hospital. Retrospective analysis of the medical records and angiograms was conducted. RESULTS: The incidence of femoral artery thrombosis after retrograde arterial catheterization, which had not responded to systemic infusion of heparin and/or urokinase, was 2.8 percent. The doses of urokinase were 1,000-4,400 unit/kg/hr and duration of infusion was 50.6+/-29.2 hours(18-110 hours). Clot resolution was complete in all patients who started to receive the intraarterial urokinase infusion within four days after catheterization. Only partial thrombolysis was seen in two patients who were treated with intraarterial urokinase on the 12th and 19th days after thrombus formation. Balloon angioplasty was done for these two patients with partial success. Bleeding complications were seen in two cases. CONCLUSION: Early use of catheter-directed intraarterial infusion of urokinase is safe and effective in thrombolysis of femoral artery occlusion after cardiac catheterization in infants and children.
